Antibodies to watch in 2024
51:01
Trends in the commercial development of antibody therapeutics: The early-stage clinical pipeline
1:01:08
Comparing Bispecific Antibody Format Feasibility
27:03
Antibody Drug Conjugates: The end of chemotherapy | 2023 West Oncology Conference
1:34:06
Quality Control Pipelines for T cell and B cell AIRR-seq
59:06
3D antibody modeling in Orion
43:28
Strategies for Mitigating the Unpredictability of Fc-Mediated Functions in Antibody Development
25:33
Trends in the early-stage clinical development of antibody therapeutics
16:47